JB Bio ApS: Financial statements 2020
CVR: 39413086
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
JB Bio ApS (CVR 39413086) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -8,438 and a net result of DKK 27,061 compared with DKK 115,181 the year before. Equity in the 2020 report amounted to DKK 102,387. The solvency ratio was 89.8%.
- Gross Profit
- DKK -8,438
- Profit/Loss
- DKK 27,061
- Equity
- DKK 102,387
- Total Assets
- DKK 114,020
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -8 t. | 27 t. | 102 t. | - |
| 2019 | - | -4 t. | 115 t. | 75 t. | - |
Official annual report
How creditworthy is JB Bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
JB Bio ApS has published its annual report for 2019. Gross profit came to DKK -3,625, and the net result was DKK 115,181.
About JB Bio ApS
JB Bio ApS was a Danish company of the type Anpartsselskab based in Horsens, founded in 2018. The company has been dissolved on 2 November 2022. The company was registered under the industry Ikke-finansielle holdingselskaber. In 2021, the company reported a gross profit of DKK -5,437 and a net result of DKK -6,488 compared with DKK 27,061 the year before. Equity in the 2021 report amounted to DKK 45,900.